Annual Influenza Vaccine

Trade Agreement: Agreement on Internal Trade (AIT) Tendering Procedures: All interested suppliers may submit a bid Attachment: YES (MERX) Electronic Competitive Procurement Strategy: Lowest/Lower Bid Comprehensive Land Claim Agreement: No Nature of Requirements: Description:

This request for proposal (RFP) is for a minimum of 2,770,000 doses of trivalent annual influenza vaccine (item 1) and 2,200,000 doses of quadrivalent annual influenza vaccine (item 2).

Up to a maximum of three (3) contracts will be awarded for trivalent annual influenza vaccine (item 1) and up to a maximum of two (2) contracts will be awarded for quadrivalent annual influenza vaccine. Resulting contracts will be for a period of one year plus two additional one-year option periods.

Items

Bidders must offer at least one of the following items

Item 1: Trivalent Influenza Vaccine with an approved indication of at least 18 years and older, as described in Annex A, Requirement. Item 2: Quadrivalent Influenza Vaccine aged 6 months and older, as described in Annex A, Requirement.

Basis of Selection

(a) To be declared responsive, a bid must: (i) comply with all the requirements of the bid solicitation; (ii) meet all mandatory criteria; and (iii) obtain a pass score for R1 in Attachment 1 to Part 4 for the technical evaluation criteria which are subject to point rating. (b) Bids not meeting (i) or (ii) or (iii) will be declared non-responsive. (c) Recommendations for contract awards for Trivalent Influenza Vaccine and Quadrivalent Influenza Vaccine will be in accordance with Part 4 - Evaluation Procedures and Basis of Selection.

Delivery Date: 19/01/2015

The Crown retains the right to negotiate with suppliers on any procurement.

Documents may be submitted in either official language of Canada.